Fonte: Frontiers in Pharmacology. Unidades: FMRP, ICB
Assuntos: MELANOMA, SISTEMA IMUNE, INFLAMAÇÃO, METÁSTASE NEOPLÁSICA
ABNT
MARIA, Andrea Gutierrez et al. Activation of the kinin B1 receptor by its agonist reduces melanoma metastasis by playing a dual effect on tumor cells and host immune response. Frontiers in Pharmacology, v. 10, n. 11, p. [13] , 2019Tradução . . Disponível em: https://doi.org/10.3389/fphar.2019.01106. Acesso em: 19 out. 2024.APA
Maria, A. G., Dillemburg-Pilla, P., Durand, M. de T., Floriano, E. M., Manfiolli, A. O., Ramos, S. G., et al. (2019). Activation of the kinin B1 receptor by its agonist reduces melanoma metastasis by playing a dual effect on tumor cells and host immune response. Frontiers in Pharmacology, 10( 11), [13] . doi:10.3389/fphar.2019.01106NLM
Maria AG, Dillemburg-Pilla P, Durand M de T, Floriano EM, Manfiolli AO, Ramos SG, Pesquero JB, Nahmias C, Costa Neto CM da. Activation of the kinin B1 receptor by its agonist reduces melanoma metastasis by playing a dual effect on tumor cells and host immune response [Internet]. Frontiers in Pharmacology. 2019 ; 10( 11): [13] .[citado 2024 out. 19 ] Available from: https://doi.org/10.3389/fphar.2019.01106Vancouver
Maria AG, Dillemburg-Pilla P, Durand M de T, Floriano EM, Manfiolli AO, Ramos SG, Pesquero JB, Nahmias C, Costa Neto CM da. Activation of the kinin B1 receptor by its agonist reduces melanoma metastasis by playing a dual effect on tumor cells and host immune response [Internet]. Frontiers in Pharmacology. 2019 ; 10( 11): [13] .[citado 2024 out. 19 ] Available from: https://doi.org/10.3389/fphar.2019.01106